top of page
Search

10/21/2025

jesse4430
Oct 21, 2025
1 min read

LANSING - Michigan lawmakers plan to save money in the state's Medicaid program by limiting the use of popular weight loss drugs to people with diabetes and those who are classified as morbidly obese. Coverage for obesity will only be allowed after other weight loss interventions have failed to prevent higher-cost bariatric surgery. The state's Medicaid program covers GLP-1 drugs like Ozempic and Mounjaro for Type 2 diabetes, as required under federal guidelines. Michigan had approved coverage in 2022 for those seeking GLP-1s for obesity. Under the new state budget, appropriations for GLP-1 drugs would be reduced by $240 million.

 
 
 

Recent Posts

See All
10/23/2026

BAYFIELD - The Bayfield County Sheriff’s Committee has reversed its recommendation for a countywide Flock camera policy, which could have included a ban. The Daily Press reports that, in a unanimous v

 
 
 
10/23/2026

GOGEBIC COUNTY - The fire risk remains high for Gogebic and Ontonagon County and much of the U.P. The Michigan Department of Natural Resources, in a press release yesterday, warning that warmer than

 
 
 
10/23/2026

UPPER MICHIGAN - Michigan’s Republican U.S. Senate Candidate Mike Rogers made a campaign stop in Marquette yesterday. Rogers outlined several issued and his plans to address problems to Michigan’s ed

 
 
 

Comments

bottom of page